Chi Wang

Chi Wang

University of Kentucky

H-index: 45

North America-United States

About Chi Wang

Chi Wang, With an exceptional h-index of 45 and a recent h-index of 36 (since 2020), a distinguished researcher at University of Kentucky,

His recent articles reflect a diverse array of research interests and contributions to the field:

Neurotensin accelerates atherosclerosis and increases circulating levels of short-chain and saturated triglycerides

Molecular signature for treatment-responsive and recurrent Wilms tumors

A kinome-wide CRISPR screen identifies CK1α as a target to overcome enzalutamide resistance of prostate cancer

Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling

Plk1 phosphorylation of PHGDH to regulate serine metabolism

Taxol-elevated PLK1 overcomes BETi-resistant in prostate cancer via triggering phosphorylation-dependent degradation of BRD4

Weighted mean difference statistics for paired data in the presence of missing values

Bayesian kinetic modeling for tracer-based metabolomic data

Chi Wang Information

University

Position

___

Citations(all)

6130

Citations(since 2020)

3696

Cited By

3706

hIndex(all)

45

hIndex(since 2020)

36

i10Index(all)

98

i10Index(since 2020)

89

Email

University Profile Page

University of Kentucky

Google Scholar

View Google Scholar Profile

Top articles of Chi Wang

Title

Journal

Author(s)

Publication Date

Neurotensin accelerates atherosclerosis and increases circulating levels of short-chain and saturated triglycerides

Atherosclerosis

Jing Li

Liping Yang

Jun Song

Baoxiang Yan

Andrew J Morris

...

2024/2/15

Molecular signature for treatment-responsive and recurrent Wilms tumors

Cancer Research

Jieyun Jiang

Derek B Allison

Ravshan Burikhanov

Saptadwipa Ganguly

Ryan A Goettl

...

2024/3/22

A kinome-wide CRISPR screen identifies CK1α as a target to overcome enzalutamide resistance of prostate cancer

Cell Reports Medicine

Jinghui Liu

Yue Zhao

Daheng He

Katelyn M Jones

Shan Tang

...

2023/4/18

Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling

PLoS Genetics

Chaohao Li

Derek B Allison

Daheng He

Fengyi Mao

Xinyi Wang

...

2023/11/21

Plk1 phosphorylation of PHGDH to regulate serine metabolism

Cancer Research

Xiongjian Rao

Derek B Allison

Robert M Flight

Yuanyuan Wu

Timothy Scott

...

2023/4/4

Taxol-elevated PLK1 overcomes BETi-resistant in prostate cancer via triggering phosphorylation-dependent degradation of BRD4

Cancer Research

Yanquan Zhang

Ka Will Fong

Fengyi Mao

Ruixin Wang

Yifan Kong

...

2023/4/4

Weighted mean difference statistics for paired data in the presence of missing values

Statistical Methods in Medical Research

Yuntong Li

Brent J Shelton

William St Clair

Heidi L Weiss

John L Villano

...

2023/10

Bayesian kinetic modeling for tracer-based metabolomic data

BMC bioinformatics

Xu Zhang

Ya Su

Andrew N Lane

Arnold J Stromberg

Teresa WM Fan

...

2023/3/22

Genomic screening methodology not requiring barcoding: Single nucleotide polymorphism-based, mixed-cell screening (SMICS)

Genomics

Zhuwei Zhang

Xi Chen

Wen Zhang

Jinpeng Liu

Yanqi Xie

...

2023/9/1

Glycolytic regulation of intestinal stem cell self-renewal and differentiation

Cellular and Molecular Gastroenterology and Hepatology

Chang Li

Yuning Zhou

Ruozheng Wei

Dana L Napier

Tomoko Sengoku

...

2023/1/1

Single-cell analysis characterizes PLK1 as a catalyst of an immunosuppressive tumor microenvironment in LUAD

bioRxiv

Yifan Kong

Chaohao Li

Jinpeng Liu

Min Zhang

Derek B Allison

...

2023/8/5

Autoencoder Networks Decipher the Association between Lung Cancer and Alzheimer’s Disease

Computational Intelligence and Neuroscience

Jialin Li

Xinliang Gao

Mingbo Tang

Chi Wang

Wei Liu

...

2022/12/5

A review on differential abundance analysis methods for mass spectrometry-based metabolomic data

Zhengyan Huang

Chi Wang

2022/3/30

Multivariate Sparse Group Lasso Joint Model for Radiogenomics Data

arXiv preprint arXiv:2206.01352

Tiantian Zeng

Md Selim

Jie Zhang

Arnold Stromberg

Jin Chen

...

2022/6/3

GSTM2 is a key molecular determinant of resistance to SG-ARIs

Oncogene

Chaohao Li

Jinpeng Liu

Daheng He

Fengyi Mao

Xiongjian Rao

...

2022/9/30

The kinase PLK1 promotes the development of Kras/Tp53-mutant lung adenocarcinoma through transcriptional activation of the receptor RET

Science signaling

Yifan Kong

Derek B Allison

Qiongsi Zhang

Daheng He

Yuntong Li

...

2022/10/4

Targetable IDH1 mutation identified in a rare case of pancreatic serous cystadenocarcinoma but not a series of serous cystadenomas

Journal of Surgical Case Reports

Yuxi Zhang

Autumn Hammonds

Karen Tran-Harding

Kurt B Schaberg

Rashmi T Nair

...

2022/3

O3 Molecular tumor board assisted care in an advanced cancer population: Results of a phase 2 clinical trial

Gynecologic Oncology

Megan Hutchcraft

Rachel Miller

Heidi Weiss

Jianrong Wu

Chi Wang

...

2022/6/1

Molecular tumor board–assisted care in an advanced cancer population: results of a phase II clinical trial

JCO Precision Oncology

Rachel W Miller

Megan L Hutchcraft

Heidi L Weiss

Jianrong Wu

Chi Wang

...

2022/9

Upregulation of CD36, a fatty acid translocase, promotes colorectal cancer metastasis by increasing MMP28 and decreasing E-cadherin expression

Cancers

James Drury

Piotr G Rychahou

Courtney O Kelson

Mariah E Geisen

Yuanyuan Wu

...

2022/1/5

See List of Professors in Chi Wang University(University of Kentucky)